Literature DB >> 12522050

Identification of B- and T-cell epitopes of BB, a carrier protein derived from the G protein of Streptococcus strain G148.

Liliane Goetsch1, Jean Francois Haeuw, Thierry Champion, Christine Lacheny, Thien N'Guyen, Alain Beck, Nathalie Corvaia.   

Abstract

Most conventional vaccines consist of killed organisms or purified antigenic proteins. Such molecules are generally poorly immunogenic and need to be coupled to carrier proteins. We have identified a new carrier molecule, BB, derived from the G protein of Streptococcus strain G148. We show that BB is able to induce strong antibody responses when conjugated to peptides or polysaccharides. In order to localize T and B cell epitopes in BB and match them with the albumin-binding region of the molecule, we immunized mice with BB, performed B and T pepscan analyses, and compared the results with pepscan done with sera and cells from humans. Our results indicate that BB has two distinct T helper epitopes, seven linear B-cell epitopes, and one conformational B-cell epitope in BALB/c mice. Four linear B-cell epitopes were identified from human sera, three of which overlapped mouse B-cell epitopes. Finally, three human T-cell epitopes were detected on the BB protein. One of these T-cell epitopes is common to BALB/c mice and humans and was localized in the region that contains the albumin-binding site. These data are of interest for the optimization of new carrier molecules derived from BB.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12522050      PMCID: PMC145282          DOI: 10.1128/cdli.10.1.125-132.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  43 in total

1.  Multi-pin peptide synthesis strategy for T cell determinant analysis.

Authors:  N J Maeji; A M Bray; H M Geysen
Journal:  J Immunol Methods       Date:  1990-11-06       Impact factor: 2.303

2.  Induction of an epitope-specific humoral immune response by lipopeptide-hapten conjugates: enhancement of the anti-melittin response by a synthetic T helper (Th)-cell epitope.

Authors:  P Hoffmann; M Loleit; K Mittenbühler; W Beck; K H Wiesmüller; G Jung; W G Bessler
Journal:  FEMS Immunol Med Microbiol       Date:  1997-04

3.  Carrier-induced epitopic suppression is initiated through clonal dominance.

Authors:  M P Schutze; E Deriaud; G Przewlocki; C LeClerc
Journal:  J Immunol       Date:  1989-04-15       Impact factor: 5.422

4.  Effect of recombinant soluble CD4 in rhesus monkeys infected with simian immunodeficiency virus of macaques.

Authors:  M Watanabe; K A Reimann; P A DeLong; T Liu; R A Fisher; N L Letvin
Journal:  Nature       Date:  1989-01-19       Impact factor: 49.962

5.  Breaking of B cell tolerance toward a highly conserved self protein.

Authors:  I Dalum; M R Jensen; P Hindersson; H I Elsner; S Mouritsen
Journal:  J Immunol       Date:  1996-12-01       Impact factor: 5.422

6.  Mapping the major human T helper epitopes of tetanus toxin. The emerging picture.

Authors:  J C Reece; H M Geysen; S J Rodda
Journal:  J Immunol       Date:  1993-12-01       Impact factor: 5.422

7.  Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination.

Authors:  D Valmori; A Pessi; E Bianchi; G Corradin
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

8.  Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines.

Authors:  C C Peeters; A M Tenbergen-Meekes; J T Poolman; M Beurret; B J Zegers; G T Rijkers
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

9.  Carrier-induced epitopic suppression, a major issue for future synthetic vaccines.

Authors:  M P Schutze; C Leclerc; M Jolivet; F Audibert; L Chedid
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

10.  A dual expression system for the generation, analysis and purification of antibodies to a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA.

Authors:  S Ståhl; A Sjölander; P A Nygren; K Berzins; P Perlmann; M Uhlén
Journal:  J Immunol Methods       Date:  1989-11-13       Impact factor: 2.303

View more
  3 in total

1.  Conjugate of Doxorubicin to Albumin-Binding Peptide Outperforms Aldoxorubicin.

Authors:  Parisa Yousefpour; Lucie Ahn; Joel Tewksbury; Soumen Saha; Simone A Costa; Joseph J Bellucci; Xinghai Li; Ashutosh Chilkoti
Journal:  Small       Date:  2019-02-13       Impact factor: 13.281

Review 2.  Early implementation of QbD in biopharmaceutical development: a practical example.

Authors:  Jesús Zurdo; Andreas Arnell; Olga Obrezanova; Noel Smith; Ramón Gómez de la Cuesta; Thomas R A Gallagher; Rebecca Michael; Yvette Stallwood; Caroline Ekblad; Lars Abrahmsén; Ingmarie Höidén-Guthenberg
Journal:  Biomed Res Int       Date:  2015-05-17       Impact factor: 3.411

3.  ABD-Derived Protein Blockers of Human IL-17 Receptor A as Non-IgG Alternatives for Modulation of IL-17-Dependent Pro-Inflammatory Axis.

Authors:  Marie Hlavničková; Milan Kuchař; Radim Osička; Lucie Vaňková; Hana Petroková; Michal Malý; Jiří Černý; Petr Arenberger; Petr Malý
Journal:  Int J Mol Sci       Date:  2018-10-09       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.